Human tissue-engineered products-Today ’ s markets and future prospects

[1]  Matthew J Dalby,et al.  Increasing fibroblast response to materials using nanotopography: morphological and genetic measurements of cell response to 13-nm-high polymer demixed islands. , 2002, Experimental cell research.

[2]  H. Humes.  Application of gene and cell therapies in the tissue engineering of a bioartificial kidney. , 1996, The International journal of artificial organs.

[3]  H. Matthew,et al.  Hybrid, Composite, and Complex Biomaterials , 2002, Annals of the New York Academy of Sciences.

[4]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[5]  Alexander M Seifalian,et al.  Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. , 2002, Artificial organs.

[6]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[7]  H. Greisler,et al.  Biomaterials in the development and future of vascular grafts. , 2003, Journal of vascular surgery.

[8]  W M Miller,et al.  Dynamic model of ex vivo granulocytic kinetics to examine the effects of oxygen tension, pH, and interleukin-3. , 2000, Experimental hematology.

[9]  Laura E Niklason,et al.  Human arteries engineered in vitro , 2003, EMBO reports.

[10]  Roland Hetzer,et al.  Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. , 2002, Tissue engineering.

[11]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[12]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[13]  A. Bader,et al.  Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. , 2002, Advances in biochemical engineering/biotechnology.

[14]  Fiona E. Murray.  Innovation as co-evolution of scientific and technological networks: exploring tissue engineering , 2002 .

[15]  E. Sim,et al.  Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. , 2003, The Annals of thoracic surgery.

[16]  M. Augustin,et al.  Chronic leg ulcers : cost evaluation of two treatment strategies , 1999 .

[17]  Jan P. Stegemann,et al.  Phenotype Modulation in Vascular Tissue Engineering Using Biochemical and Mechanical Stimulation , 2003, Annals of Biomedical Engineering.

[18]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[19]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[20]  Eugene Khor,et al.  Implantable applications of chitin and chitosan. , 2003, Biomaterials.

[21]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[22]  Humes Hd,et al.  Bioartificial kidney for full renal replacement therapy. , 2000 .

[23]  P. Wernet,et al.  [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. , 2001, Deutsche medizinische Wochenschrift.

[24]  C. Verfaillie.  Adult stem cells: assessing the case for pluripotency. , 2002, Trends in cell biology.

[25]  R. Martin,et al.  A guide to biological skin substitutes. , 2002, British journal of plastic surgery.

[26]  Cato T Laurencin,et al.  Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. , 2003, Journal of biomedical materials research. Part A.

[27]  P. Revell,et al.  Differential expression of transforming growth factor‐α and macrophage colony‐stimulating factor/colony‐stimulating factor‐1R (c‐fms) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[29]  M. Toner,et al.  Storage and Translational Issues in Reparative Medicine , 2002, Annals of the New York Academy of Sciences.

[30]  S. Parente.  Estimating the economic cost offsets of using Dermagraft-TC as an alternative to cadaver allograft in the treatment of graftable burns. , 1997, The Journal of burn care & rehabilitation.

[31]  W. Konertz,et al.  Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. , 2000, The Journal of thoracic and cardiovascular surgery.

[32]  M. B. Claase,et al.  Porous PEOT/PBT scaffolds for bone tissue engineering: preparation, characterization, and in vitro bone marrow cell culturing. , 2002, Journal of biomedical materials research. Part A.

[33]  Matthew J Dalby,et al.  Nucleus alignment and cell signaling in fibroblasts: response to a micro-grooved topography. , 2003, Experimental cell research.

[34]  P. Thomsen,et al.  In vitro study of monocyte viability during the initial adhesion to albumin- and fibrinogen-coated surfaces. , 2001, Biomaterials.

[35]  Magdalena Fossum,et al.  ISOLATION AND IN VITRO CULTIVATION OF HUMAN UROTHELIAL CELLS FROM BLADDER WASHINGS OF ADULT PATIENTS AND CHILDREN , 2003, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[36]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[37]  G. Vogel.  Studies Cast Doubt on Plasticity of Adult Cells , 2002, Science.

[38]  G. Vogel,et al.  Plasticity: Time for a Reappraisal? , 2002, Science.

[39]  Ulrich M. Gassner.  Tissue Engineering im Normendschungel , 2001 .

[40]  J. Posnett,et al.  Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. , 2000, Diabetes & metabolism.

[41]  Farshid Guilak,et al.  Functional Tissue Engineering , 2002, Annals of the New York Academy of Sciences.

[42]  Michael J Lysaght,et al.  Private sector development of stem cell technology and therapeutic cloning. , 2003, Tissue engineering.

[43]  M. Heidaran,et al.  Molecular Signaling in Bioengineered Tissue Microenvironments , 2002, Annals of the New York Academy of Sciences.

[44]  R. Langer,et al.  Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications , 2002, Science.

[45]  D. F. Williams,et al.  The Williams dictionary of biomaterials , 1999 .

[46]  D. Williams,et al.  Macrophage subpopulation differentiation by stimulation with biomaterials. , 1997, Journal of biomedical materials research.

[47]  S. C. Huang,et al.  Multilineage Potential of Homozygous Stem Cells Derived from Metaphase II Oocytes , 2003, Stem cells.

[48]  Ulf Persson,et al.  Resource use and costs in a Swedish cohort of patients with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[49]  A Curtis,et al.  Tissue engineering: the biophysical background. , 2001, Physics in medicine and biology.

[50]  Johnny Huard,et al.  Gene therapy and tissue engineering based on muscle-derived stem cells. , 2002, Current opinion in molecular therapeutics.

[51]  B. Bloom,et al.  Cost of illness of Alzheimer's disease: how useful are current estimates? , 2003, The Gerontologist.

[52]  S. Boden,et al.  The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.

[53]  D. W. Jackson,et al.  THE ARTICULAR CARTILAGE REPAIR DILEMMA Symptomatic Articular Cartilage Degeneration , 2001 .

[54]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[55]  S. Meaume,et al.  Cost-effectiveness of wound management in France: pressure ulcers and venous leg ulcers. , 2002, Journal of wound care.

[56]  W. Mark Saltzman,et al.  Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.

[57]  R. Bareille,et al.  Cultured differentiated human urothelial cells in the biomaterials field. , 2000, Biomaterials.

[58]  R. Satava.  Disruptive visions: Moral and ethical challenges from advanced technology and issues for the new generation of surgeons , 2002 .

[59]  G. Keilhoff,et al.  Reconstruction of peripheral nerves using acellular nerve grafts with implanted cultured Schwann cells , 2002, Microsurgery.

[60]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[61]  Bartolozzi,et al.  Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors , 2000, British journal of haematology.

[62]  Heinrich Planck,et al.  Rat Schwann cells in bioresorbable nerve guides to promote and accelerate axonal regeneration , 2003, Brain Research.

[63]  Kytai Truong Nguyen,et al.  Photopolymerizable hydrogels for tissue engineering applications. , 2002, Biomaterials.

[64]  Antonios G Mikos,et al.  Biomaterials and Scaffolds in Reparative Medicine , 2002, Annals of the New York Academy of Sciences.

[65]  P. Ducheyne,et al.  In vivo evaluation of a bioactive scaffold for bone tissue engineering. , 2002, Journal of biomedical materials research.

[66]  Constance M. Chen,et al.  New directions in bioabsorbable technology. , 2002, Journal of neurosurgery.

[67]  S. Petit-Zeman,et al.  Regenerative medicine , 2001, Nature Biotechnology.

[68]  K. Shakesheff,et al.  Growth factor release from tissue engineering scaffolds , 2001, The Journal of pharmacy and pharmacology.

[69]  C. Kirkpatrick,et al.  Tissue response and biomaterial integration: the efficacy of in vitro methods. , 2002, Biomolecular engineering.

[70]  Makarand V Risbud,et al.  Tissue engineering: advances in in vitro cartilage generation. , 2002, Trends in biotechnology.

[71]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[72]  U A Stock,et al.  Tissue engineering of heart valves -- current aspects. , 2002, The Thoracic and cardiovascular surgeon.

[73]  Takehisa Matsuda,et al.  Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. , 2003, Tissue engineering.

[74]  A. Mikos,et al.  Adhesion and migration of marrow-derived osteoblasts on injectable in situ crosslinkable poly(propylene fumarate-co-ethylene glycol)-based hydrogels with a covalently linked RGDS peptide. , 2003, Journal of biomedical materials research. Part A.

[75]  Jan Feijen,et al.  Biodegradable elastomeric scaffolds for soft tissue engineering. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[76]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[77]  M J Lysaght,et al.  The growth of tissue engineering. , 2001, Tissue engineering.

[78]  B. Byrne,et al.  Myoblast cell grafting into heart muscle: cellular biology and potential applications. , 1999, Annual review of physiology.

[79]  M S Chapekar,et al.  Tissue engineering: challenges and opportunities. , 2000, Journal of biomedical materials research.

[80]  Yan Li,et al.  Autologous cell transplantation and cardiac tissue engineering: potential applications in heart failure. , 2003, Biorheology.

[81]  Jeffrey A Hubbell,et al.  Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. , 2003, Biomaterials.

[82]  V. Falanga,et al.  An economic assessment of Apligraf® (Graftskin) for the treatment of hard‐to‐heal venous leg ulcers , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[83]  L W Rue,et al.  Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. , 1992, The Journal of trauma.

[84]  B. Fleischmann,et al.  Cellular Cardiomyoplasty Improves Survival After Myocardial Injury , 2002, Circulation.

[85]  P. Zilla,et al.  Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. , 1999, Surgery.